Skip to main content
. 2022 Dec 12;12:1042525. doi: 10.3389/fonc.2022.1042525

Figure 6.

Figure 6

CT-scan performed in October 2022, 13 months after the beginning of treatment, showing a further tumor volume reduction of left thyroid lobe (2,3x2,7cm) (A), of latero-cervical lymphadenopathies (maximum diameter of 1,3 cm) (B), and a complete radiological response of brain metastases (C).